AU4879496A - Antiviral combinations of bch-189 and ritonavir - Google Patents

Antiviral combinations of bch-189 and ritonavir

Info

Publication number
AU4879496A
AU4879496A AU48794/96A AU4879496A AU4879496A AU 4879496 A AU4879496 A AU 4879496A AU 48794/96 A AU48794/96 A AU 48794/96A AU 4879496 A AU4879496 A AU 4879496A AU 4879496 A AU4879496 A AU 4879496A
Authority
AU
Australia
Prior art keywords
ritonavir
bch
antiviral combinations
antiviral
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48794/96A
Inventor
Hugh Brownlie Mcdade
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU4879496A publication Critical patent/AU4879496A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
AU48794/96A 1995-02-25 1996-02-22 Antiviral combinations of bch-189 and ritonavir Abandoned AU4879496A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9503850.1A GB9503850D0 (en) 1995-02-25 1995-02-25 Medicaments
GB9503850 1995-02-25
PCT/EP1996/000736 WO1996026734A1 (en) 1995-02-25 1996-02-22 Antiviral combinations of bch-189 and ritonavir

Publications (1)

Publication Number Publication Date
AU4879496A true AU4879496A (en) 1996-09-18

Family

ID=10770279

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48794/96A Abandoned AU4879496A (en) 1995-02-25 1996-02-22 Antiviral combinations of bch-189 and ritonavir

Country Status (6)

Country Link
EP (1) EP0810873A1 (en)
JP (1) JPH11501303A (en)
AU (1) AU4879496A (en)
CA (1) CA2213621A1 (en)
GB (1) GB9503850D0 (en)
WO (1) WO1996026734A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0938321B1 (en) 1996-06-25 2004-01-14 Glaxo Group Limited Combinations comprising vx478, zidovudine and 3tc for use in the treatment of hiv
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
FR2779653B1 (en) 1998-06-11 2002-12-20 Inst Nat Sante Rech Med USE OF PROTEASOME MODULATING COMPOUNDS IN THERAPY
FR2878747B1 (en) * 2004-12-03 2007-03-30 Pierre Fabre Medicament Sa USE OF OMEGA-3 FATTY ACID (S) FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA CAUSED BY ANTI-RETROVIRAL TREATMENT IN HIV INFECTED PATIENTS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992010496A1 (en) * 1990-12-05 1992-06-25 University Of Georgia Research Foundation, Inc. ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES
SK279262B6 (en) * 1991-05-16 1998-08-05 Glaxo Group Limited Antiviral combination, pharmaceutical composition containing thereof and its use
ATE184787T1 (en) * 1992-05-13 1999-10-15 Wellcome Found THERAPEUTIC COMBINATIONS
GB9215178D0 (en) * 1992-07-16 1992-08-26 Glaxo Group Ltd Antiviral combinations
UA49803C2 (en) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Method for treatment of retrovirus infections

Also Published As

Publication number Publication date
CA2213621A1 (en) 1996-09-06
GB9503850D0 (en) 1995-04-19
EP0810873A1 (en) 1997-12-10
WO1996026734A1 (en) 1996-09-06
JPH11501303A (en) 1999-02-02

Similar Documents

Publication Publication Date Title
AU7296896A (en) Purine derivatives and processes for their preparation
IL116831A0 (en) Guanine derivatives its preparation and use
AU7334194A (en) Characteristic of body part determined
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU8448491A (en) Antiviral compounds and antihypertensive compounds
AU4772493A (en) Sulfo-derivatives of adenosine
AU2670695A (en) Preparation of purines
AU6938696A (en) Liferafts
AU6135896A (en) Antiviral agents
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU2377097A (en) Antiviral ricin-like proteins
AU6723294A (en) Use of simmondsine
AU5883794A (en) Diazepin derivatives and antiviral compositions
AU4879496A (en) Antiviral combinations of bch-189 and ritonavir
AU7544396A (en) Triazole derivatives and uses thereof
AU5737494A (en) Human thrombospondin-4
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU7863994A (en) Antiviral drug
AU6015096A (en) Antiviral method and antiviral agent
AU6975996A (en) Stabilized agchemical concentrate and use thereof
AU5188296A (en) Carbopeptoids and carbonucleotoids
AU1900195A (en) Anti-viral and anti-cancer agents
AU3395295A (en) Alkaloids and their antiviral agents
AU4159596A (en) Antiviral and antitumor pharmaceutical compositions
AU5115396A (en) Anti-viral and anti-cancer agents

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted